Impact of mirikizumab treatment on fatigue in patients with moderately to severely active Crohn's disease: results from the phase 3 VIVID-1 study
mirikizumab治疗对中重度活动性克罗恩病患者疲劳的影响:VIVID-1 III期研究结果
期刊:Journal of Crohns & Colitis
影响因子:8.7
doi:10.1093/ecco-jcc/jjaf100
Regueiro, Miguel; Fischer, Monika; Bossuyt, Peter; Protic, Marijana; Traxler, Kristina; Yu, Guanglei; Zang, Huaiyu; Vadhariya, Aisha; Hisamatsu, Tadakazu; Juillerat, Pascal; Armuzzi, Alessandro; Gisbert, Javier P; Walsh, Alissa